QPS Awarded Two 2020 CRO Leadership Awards
PR84120
NEWARK, Delaware, June 2, 2020 /PRNewswire=KYODO JBN/ --
QPS (
https://c212.net/c/link/?t=0&l=en&o=2811249-1&h=2308182837&u=https%3A%2F%2Fwww.qps.com%2F&a=QPS
) is a GLP/GCP-compliant and CLIA-certified contract research organization
(CRO) delivering discovery, preclinical, and clinical drug development services
since 1995. An award-winning leader focused on bioanalytics and clinical
trials, QPS, has been awarded two 2020 CRO Leadership Awards (
) by Life Science Leader magazine. Recognized by its customers for exceeding
their expectations, QPS was honored in two core categories: Expertise (Big
Pharma) and Reliability (Big Pharma).
Logo -
https://mma.prnewswire.com/media/1171746/CRO_Leadership_Awards_and_the_QPS_Logo.jpg
To determine the recipients of these annual awards, Life Science Leader (
) and Clinical Leader (
) collaborate with Industry Standard Research (ISR) (
), a full-service pharma market research firm, to assess 60 CROs on over 20
performance metrics. In 2019, QPS also received two CRO Leadership Awards,
which recognized QPS for excellence in Reliability (Big Pharma) and Quality
(Big Pharma).
Recruited from pharmaceutical and biopharmaceutical companies of various sizes,
the survey participants only evaluated those companies with which they had
worked on an outsourced project within the past 18 months. They also underwent
a stringent screening process to ensure that their responses reflected their
actual experiences with the CROs, not their perceptions of them.
"QPS is honored to receive this recognition in two key categories – Expertise
and Reliability," said Benjamin Chien, CEO of QPS. "We take great pride in our
global lab capability and capacity as well as our high-quality clinical trials.
Our partners know they can rely on the expertise of the scientists in our
GLP/GCP-compliant and CLIA-certified bioanalysis laboratories to provide
reliable, top-of-the-line data. We are delighted that our team members are
being recognized for their hard work."
The CRO Leadership Awards were developed in 2012 to facilitate the vetting
process for selecting outsourcing partners. "When talking to clinical
operations executives, I'm told the CRO selection process can be one of their
most stressful and time-consuming chores," says Ed Miseta, chief editor,
Clinical Leader. "Anything we can do to help steer our readers to those
partners that best meet their needs can significantly reduce the burden of
their search. That is why we are once again proud to partner with Industry
Standard Research to produce our annual CRO Leadership Awards. The
organizations being honored have proven themselves to be the top performers in
Compatibility, Capabilities, Expertise, Quality, Reliability, and Phase IV. We
applaud these companies for their hard work in meeting the needs and
expectations of their pharma and biotech clients."
ABOUT QPS HOLDINGS, LLC
The company is a global contract research organization (CRO) providing
discovery, preclinical and clinical drug development services since 1995. QPS
has CLIA-certified and GLP-compliant laboratories ready to fast-track novel
coronavirus RT-qPCR/QPCR and Serological Assays and vaccine development
programs. An award-winning leader focused on bioanalytics and clinical trials,
QPS is known for proven quality standards, technical expertise, a flexible
approach to research, client satisfaction, and turnkey laboratories and
facilities. For more information, visit www.qps.com or email infopr@qps.com.
QPS CONTACT:
Name: Gabrielle Pastore
Phone: 1-302-369-5274
Email: Gabrielle.Pastore@qps.com
SOURCE : QPS
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。
